Muskat, A. et al. 2022. A rare case of erythema dyschromicum perstans arising in the setting of a third-generation tyrosine kinase inhibitor. Acta Oncologica. 61, 7 (Jul. 2022), 830–832. DOI:https://doi.org/10.1080/0284186X.2022.2082258.